U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H19FN4O3
Molecular Weight 370.3776
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BRIVANIB

SMILES

C[C@@H](O)COC1=CN2N=CN=C(OC3=C(F)C4=C(NC(C)=C4)C=C3)C2=C1C

InChI

InChIKey=WCWUXEGQKLTGDX-LLVKDONJSA-N
InChI=1S/C19H19FN4O3/c1-10-6-13-14(23-10)4-5-15(17(13)20)27-19-18-12(3)16(26-8-11(2)25)7-24(18)22-9-21-19/h4-7,9,11,23,25H,8H2,1-3H3/t11-/m1/s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
BRIVANIB
MI   USAN   WHO-DD  
USAN  
Official Name English
BRIVANIB [USAN]
Common Name English
BMS-540215
Code English
2-PROPANOL, 1-((4-((4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY)-5-METHYLPYRROLO(2,1-F)(1,2,4)TRIAZIN-6-YL)OXY)-, (2R)-
Systematic Name English
Brivanib [WHO-DD]
Common Name English
BRIVANIB [MI]
Common Name English
(2R)-1-({4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-ol
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C1967
Created by admin on Fri Dec 15 16:15:22 UTC 2023 , Edited by admin on Fri Dec 15 16:15:22 UTC 2023
NCI_THESAURUS C1742
Created by admin on Fri Dec 15 16:15:22 UTC 2023 , Edited by admin on Fri Dec 15 16:15:22 UTC 2023
Code System Code Type Description
NCI_THESAURUS
C67040
Created by admin on Fri Dec 15 16:15:22 UTC 2023 , Edited by admin on Fri Dec 15 16:15:22 UTC 2023
PRIMARY
PUBCHEM
11234052
Created by admin on Fri Dec 15 16:15:22 UTC 2023 , Edited by admin on Fri Dec 15 16:15:22 UTC 2023
PRIMARY
ChEMBL
CHEMBL377300
Created by admin on Fri Dec 15 16:15:22 UTC 2023 , Edited by admin on Fri Dec 15 16:15:22 UTC 2023
PRIMARY
MERCK INDEX
m2653
Created by admin on Fri Dec 15 16:15:22 UTC 2023 , Edited by admin on Fri Dec 15 16:15:22 UTC 2023
PRIMARY Merck Index
MESH
C509922
Created by admin on Fri Dec 15 16:15:22 UTC 2023 , Edited by admin on Fri Dec 15 16:15:22 UTC 2023
PRIMARY
EPA CompTox
DTXSID60215294
Created by admin on Fri Dec 15 16:15:22 UTC 2023 , Edited by admin on Fri Dec 15 16:15:22 UTC 2023
PRIMARY
CHEBI
167686
Created by admin on Fri Dec 15 16:15:22 UTC 2023 , Edited by admin on Fri Dec 15 16:15:22 UTC 2023
PRIMARY
FDA UNII
DDU33B674I
Created by admin on Fri Dec 15 16:15:22 UTC 2023 , Edited by admin on Fri Dec 15 16:15:22 UTC 2023
PRIMARY
SMS_ID
100000127529
Created by admin on Fri Dec 15 16:15:22 UTC 2023 , Edited by admin on Fri Dec 15 16:15:22 UTC 2023
PRIMARY
DRUG BANK
DB11958
Created by admin on Fri Dec 15 16:15:22 UTC 2023 , Edited by admin on Fri Dec 15 16:15:22 UTC 2023
PRIMARY
USAN
WW-39
Created by admin on Fri Dec 15 16:15:22 UTC 2023 , Edited by admin on Fri Dec 15 16:15:22 UTC 2023
PRIMARY
EVMPD
SUB33565
Created by admin on Fri Dec 15 16:15:22 UTC 2023 , Edited by admin on Fri Dec 15 16:15:22 UTC 2023
PRIMARY
CAS
649735-46-6
Created by admin on Fri Dec 15 16:15:22 UTC 2023 , Edited by admin on Fri Dec 15 16:15:22 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of BRIVANIB
PRODRUG (METABOLITE ACTIVE)
Structure of BRIVANIB ALANINATE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966